Combined Chemotherapy and Immunotherapy Shows Promise for Advanced Prostate Cancers
April 29, 2015
…near complete remission in mouse models of advanced prostate cancer. The study is published April 29 in Nature.
Your search for “Cancer Immunotherapy” returned 120 results
UC San Diego Moores Cancer Center’s J. Silvio Gutkind Joins National Academy of Medicine
October 21, 2019
J. Silvio Gutkind elected to National Academy of Medicine for his contributions to the understanding of cancer signaling networks and pioneering the study of the PIK3CA-mTOR signaling circuitry in head and neck cancer.
Researchers Shed Light on Why a Certain Plant Virus Is So Powerful at Fighting Cancer
April 27, 2022
The cowpea mosaic virus has shown great promise as an experimental cancer immunotherapy for treating and preventing recurrence of various cancers. But just how the virus triggers such a potent anti-cancer immune response has remained a mystery. A new study digs deeper and provides answers.
CIRM Approves $5.8 Million Grant for CAR-T Therapy that Targets Cancer Stem Cells
July 20, 2017
…Diego School of Medicine researchers to develop a new immunotherapy in which patients’ cells would be equipped with a special receptor that recognizes and targets cancer stem cells, whose survival abilities often render standard therapies ineffective or short-term.
State Stem Cell Agency Awards $4M for Blood Cancer Immunotherapy at UC San Diego
November 24, 2021
The California Institute for Regenerative Medicine (CIRM) approved a $4.1 million grant to enable University of California San Diego School of Medicine researchers to advance a new chimeric antigen receptor (CAR) T-cell therapy from the laboratory into the clinic.
CIRM Approves New Funding to UC San Diego Researchers Fighting Zika Virus and Cancer
January 20, 2017
…stem cell-derived natural killer (NK) cells to target ovarian cancer and other malignancies.
A New Strategy to Transform Liver Cancer Immunotherapy
December 7, 2021
UC San Diego researchers identify new strategy to improve efficacy of immunotherapy on resistant liver cancers.
UC San Diego Cancer Biologist Receives Claugus Award for Medical Research
October 11, 2023
University of California San Diego cancer biologist Tatiana Hurtado de Mendoza has been named the recipient of the 2023 Claugus Award for Medical Research. The award was established in 2021 by the Foundation For A Better World.
Molecular Switch Controlling Immune Suppression May Help Turn Up Immunotherapies
September 19, 2016
…of Medicine and Moores Cancer Center have identified a strategy to maximize the effectiveness of anti-cancer immune therapy. The researchers identified a molecular switch that controls immune suppression, opening the possibility to further improving and refining emerging immunotherapies that boost the body’s own abilities to fight diseases ranging from cancer…
‘Doctor of Philanthropy’ Gives $1 Million Gift toward Blood Cancer Research
June 18, 2020
In gratitude for his cancer care, Robert J. Shillman recently donated $1 million to support the clinical and research mission of the Bone and Marrow Transplantation Program at UC San Diego Health. Photographed by Melissa Jacobs prior to the pandemic. ‘Doctor of Philanthropy’ Gives $1 Million Gift toward Blood Cancer…
